Intramyocardial Bone Marrow Cell Injection for Chronic Myocardial Ischemia: A Randomized Controlled Trial
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
CONTEXT: Previous studies have suggested that bone marrow cell injection may improve myocardial perfusion and left ventricular (LV) function in patients with chronic myocardial ischemia. OBJECTIVE: To investigate the effect of intramyocardial bone marrow cell injection on myocardial perfusion and LV function in patients with chronic myocardial ischemia. DESIGN, SETTING, AND PATIENTS: Randomized, double-blind, placebo-controlled trial at a Netherlands university hospital, May 1, 2005-March 3, 2008 (6-month follow-up ended September 2008) of 50 patients with chronic myocardial ischemia (mean age [SD], 64 [8] years; 43 men). INCLUSION CRITERIA: severe angina pectoris despite optimal medical therapy and myocardial ischemia. All patients were ineligible for conventional revascularization. INTERVENTIONS: Intramyocardial injection of 100 x 10(6) autologous bone marrow-derived mononuclear cells or placebo solution. MAIN OUTCOME MEASURES: Primarily, the summed stress score, a 17-segment score for stress myocardial perfusion assessed by Tc-99m tetrofosmin single-photon emission computed tomography (SPECT). Secondary included LV ejection fraction (LVEF), Canadian Cardiovascular Society (CCS) class, and Seattle Angina Questionnaire quality-of-life score (mean difference >5% considered clinically significant). RESULTS: After 3-month follow-up, the summed stress score (mean [SD]) improved from 23.5 (4.7) to 20.1 (4.6) (P < .001) in the bone marrow cell group, compared with a decrease from 24.8 (5.5) to 23.7 (5.4) (P = .004) in the placebo group. In the bone marrow cell-treated patients who underwent magnetic resonance imaging (MRI), a 3% absolute increase in LVEF was observed at 3 months (95% CI, 0.5% to 4.7%; n = 18), but the placebo group showed no improvement. CCS angina score improved significantly in the bone marrow cell group (6-month absolute difference, -0.79; 95% CI, -1.10 to -0.48; P < .001) compared with no significant improvement in the placebo group. Quality-of-life score increased from 56% (9%) to 64% (12%) at 3 months and 69% (12%) at 6 months in bone marrow cell-treated patients, compared with a smaller increase in the placebo group from 57% (11%) to 61% (14%) to 64% (17%). The improvements in CCS class and quality of life score were significantly greater in bone marrow cell-treated patients than in placebo-treated patients (P = .03 and P = .04, respectively). CONCLUSIONS: In this short-term study of patients with chronic myocardial ischemia refractory to medical treatment, intramyocardial bone marrow cell injection resulted in a statistically significant but modest improvement in myocardial perfusion compared with placebo. Further studies are required to assess long-term results and efficacy for mortality and morbidity. TRIAL REGISTRATIONS: trialregister.nl Identifier: NTR400 and isrctn.org Identifier: ISRCTN58194927.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging:, Cerqueira, M. D., Weissman, N. J., Dilsizian, V., Jacobs, A. K., Kaul, S., Laskey, W. K., Pennell, D. J., Rumberger, J. A., Ryan, T., et al. (2002) · Circulation · doi:10.1161/hc0402.102975 · Cited by 6,990
Wollert, K. C., Meyer, G. P., Lotz, J., Ringes Lichtenberg, S., Lippolt, P., Breidenbach, C., Fichtner, S., Korte, T., Hornig, B., Messinger, D., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16626-9 · Cited by 2,191
Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction
Schächinger, V., Erbs, S., Elsässer, A., Haberbosch, W., Hambrecht, R., Hölschermann, H., Yu, J., Corti, R., Mathey, D. G., Hamm, C. W., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060186 · Cited by 1,890
Letter: Grading of angina pectoris.
Campeau, L. (1976) · Circulation · doi:10.1161/circ.54.3.947585 · Cited by 1,601
Spertus, J. A., Winder, J. A., Dewhurst, T. A., Deyo, R. A., Prodzinski, J., McDonnell, M., & Fihn, S. D. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00397-9 · Cited by 1,385
Intracoronary Injection of Mononuclear Bone Marrow Cells in Acute Myocardial Infarction
Lunde, K., Solheim, S., Aakhus, S., Arnesen, H., Abdelnoor, M., Egeland, T., Endresen, K., Ilebekk, A., Mangschau, A., Fjeld, J. G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055706 · Cited by 1,310
Tse, H.-F., Kwong, Y.-L., Chan, J. K., Lo, G., Ho, C.-L., & Lau, C.-P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12111-3 · Cited by 850
Silva, G. V., Litovsky, S., Assad, J. A. R., Sousa, A. L. S., Martin, B. J., Vela, D., Coulter, S. C., Lin, J., Ober, J., Vaughn, W. K., et al. (2005) · Circulation · doi:10.1161/01.cir.0000151812.86142.45 · Cited by 801
Losordo, D. W., Schatz, R. A., White, C. J., Udelson, J. E., Veereshwarayya, V., Durgin, M., Poh, K. K., Weinstein, R., Kearney, M., Chaudhry, M., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.687376 · Cited by 557
Cited by
Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine
Murphy, M. B., Moncivais, K., & Caplan, A. I. (2013) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.94 · Cited by 1,231
Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina
Losordo, D. W., Henry, T. D., Davidson, C., Sup Lee, J., Costa, M. A., Bass, T., Mendelsohn, F., Fortuin, F. D., Pepine, C. J., Traverse, J. H., et al. (2011) · Circulation Research · doi:10.1161/circresaha.111.245993 · Cited by 482
Perin, E. C., Willerson, J. T., Pepine, C. J., Henry, T. D., Ellis, S. G., Zhao, D. X. M., Silva, G. V., Lai, D., Thomas, J. D., Kronenberg, M. W., et al. (2012) · JAMA · doi:10.1001/jama.2012.418 · Cited by 460
Jeevanantham, V., Butler, M., Saad, A., Abdel-Latif, A., Zuba-Surma, E. K., & Dawn, B. (2012) · Circulation · doi:10.1161/circulationaha.111.086074 · Cited by 446
Boogers, M. J., Borleffs, C. J. W., Henneman, M. M., van Bommel, R. J., van Ramshorst, J., Boersma, E., Dibbets-Schneider, P., Stokkel, M. P., van der Wall, E. E., Schalij, M. J., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.12.066 · Cited by 368
Self-citationMathiasen, A. B., Qayyum, A. A., Jørgensen, E., Helqvist, S., Fischer-Nielsen, A., Kofoed, K. F., Haack-Sørensen, M., Ekblond, A., & Kastrup, J. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv136 · Cited by 344
Chronic Coronary Artery Disease: Diagnosis and Management
Cassar, A., Holmes, D. R., Rihal, C. S., & Gersh, B. J. (2009) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0391 · Cited by 324
Gyöngyösi, M., Wojakowski, W., Lemarchand, P., Lunde, K., Tendera, M., Bartunek, J., Marban, E., Assmus, B., Henry, T. D., Traverse, J. H., et al. (2015) · Circulation Research · doi:10.1161/circresaha.116.304346 · Cited by 313
Self-citationBastings, M. M. C., Koudstaal, S., Kieltyka, R. E., Nakano, Y., Pape, A. C. H., Feyen, D. A. M., van Slochteren, F. J., Doevendans, P. A., Sluijter, J. P. G., Meijer, E. W., et al. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201300076 · Cited by 311
Adult Stem Cell Therapy and Heart Failure, 2000 to 2016: A Systematic Review
Nguyen, P. K., Rhee, J.-W., & Wu, J. C. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.2225 · Cited by 299
Cell therapy for cardiac repair—lessons from clinical trials
Behfar, A., Crespo-Diaz, R., Terzic, A., & Gersh, B. J. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.9 · Cited by 292
Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: The PRECISE Trial
Perin, E. C., Sanz-Ruiz, R., Sánchez, P. L., Lasso, J., Pérez-Cano, R., Alonso-Farto, J. C., Pérez-David, E., Fernández-Santos, M. E., Serruys, P. W., Duckers, H. J., et al. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.03.022 · Cited by 283
Trophic Effects of Mesenchymal Stem Cells in Tissue Regeneration
Fu, Y., Karbaat, L., Wu, L., Leijten, J., Both, S. K., & Karperien, M. (2017) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2016.0365 · Cited by 276
Postischemic Revascularization: From Cellular and Molecular Mechanisms to Clinical Applications
Silvestre, J.-S., Smadja, D. M., & Lévy, B. I. (2013) · Physiological Reviews · doi:10.1152/physrev.00006.2013 · Cited by 255
Stem cell therapy for chronic ischaemic heart disease and congestive heart failure
Fisher, S. A., Doree, C., Mathur, A., Taggart, D. P., & Martin-Rendon, E. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007888.pub3 · Cited by 254
Cell therapy for the treatment of coronary heart disease: a critical appraisal
Wollert, K. C., & Drexler, H. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.1 · Cited by 251
Li, L., Wang, Y., Guo, R., Li, S., Ni, J., Gao, S., Gao, X., Mao, J., Zhu, Y., Wu, P., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.11.032 · Cited by 189
Metadata
- Authors
- van Ramshorst, J., Bax, J. J., Beeres, S. L. M. A., Dibbets-Schneider, P., Roes, S. D., Stokkel, M. P. M., de Roos, A., Fibbe, W. E., Zwaginga, J. J., Boersma, E., Schalij, M. J., & Atsma, D. E.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2009-05-20
- Volume
- 301
- Issue
- 19
- Pages
- 1997
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2009293798
- Cited by
- 300
- References
- 20
- FWCI
- 17.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.